FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,350,000 | -10.2% | 104,881 | -0.7% | 0.07% | -5.5% |
| Q2 2022 | $2,617,000 | -36.8% | 105,606 | -1.1% | 0.07% | -25.5% |
| Q1 2022 | $4,141,000 | -33.2% | 106,800 | +0.8% | 0.10% | -25.2% |
| Q4 2021 | $6,199,000 | -17.7% | 105,952 | -16.6% | 0.13% | -22.5% |
| Q3 2021 | $7,534,000 | -21.5% | 127,110 | +15.0% | 0.17% | -18.0% |
| Q2 2021 | $9,593,000 | +474.4% | 110,526 | +47.0% | 0.21% | +237.7% |
| Q1 2020 | $1,670,000 | – | 75,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |